442 related articles for article (PubMed ID: 15163541)
1. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
2. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.
Arora V; Mondal AM; Grover R; Kumar A; Chattopadhyay P; Das N
Mol Immunol; 2007 Mar; 44(7):1722-8. PubMed ID: 17049990
[TBL] [Abstract][Full Text] [Related]
3. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
5. Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: a follow-up study.
Arora V; Grover R; Kumar A; Anand D; Das N
Lupus; 2011 Oct; 20(10):1010-8. PubMed ID: 21659422
[TBL] [Abstract][Full Text] [Related]
6. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
7. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
8. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
[TBL] [Abstract][Full Text] [Related]
11. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
12. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
[TBL] [Abstract][Full Text] [Related]
14. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
15. [The role of CR1 complement receptor in pathology].
Rochowiak A; Niemir ZI
Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
[TBL] [Abstract][Full Text] [Related]
16. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
[TBL] [Abstract][Full Text] [Related]
17. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
19. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
Said PB; Sarano J; Manni JA; Casellas AM
Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA
J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]